Cite
APA Citation
Kimura, T., Kawaguchi, T., Chiba, Y., Yoshioka, H., Watanabe, K., Kijima, T., Kogure, Y., Oguri, T., Yoshimura, N., Niwa, T., Kasai, T., Hayashi, H., Ono, A., Asai, K., Tanaka, H., Yano, S., Yamamoto, N., Nakanishi, Y., & Nakagawa, K. (2019). phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L). Japanese journal of clinical oncology, 49, 947–955. http://access.bl.uk/ark:/81055/vdc_100098039030.0x00003c